In this week's GameChangers we explore the emerging role of colchicine in the secondary prevention of cardiovascular disease. Drs. Wall and Boyd discuss colchicine's anti-inflammatory benefits, the challenges posed by side effects and drug interactions, and the latest research shaping its future in clinical practice. 

The GameChanger
Colchicine shows potential for secondary prevention in cardiovascular disease due to its anti-inflammatory properties, but its clinical use is limited by gastrointestinal side effects and drug interactions. 

 
Host
Geoff Wall, PharmD, BCPS, FCCP, BCGP
Professor of Pharmacy Practice, Drake University
Internal Medicine/Critical Care, UnityPoint Health

Mathew Boyd, PharmD
Clinical Pharmacist, Unity Point

Reference
Meta-Analysis
Clear Synergy Study

Pharmacist Members, REDEEM YOUR CPE HERE!
 
Not a member? Get a Pharmacist Membership & earn CE for GameChangers Podcast episodes! (30 mins/episode)


CPE Information
 
Learning Objectives
Upon successful completion of this knowledge-based activity, participants should be able to:
1. Identify the potential benefits of colchicine in secondary prevention of cardiovascular disease based on its anti-inflammatory properties.
2. Discuss the limitations of colchicine use in clinical practice, including gastrointestinal side effects and drug interactions.

0.05 CEU/0.5 Hr
UAN: 0107-0000-24-190-H01-P
Initial release date: 06/17/2024
Expiration date: 06/17/2025
Additional CPE details can be found here.

Follow CEimpact on Social Media:
LinkedIn
Instagram